Global Deep Brain Stimulation Market Size to Reach USD 4.27 Billion in 2032 | Emergen Research


Technological advancements in Deep Brain Stimulation (DBS), significant prevalence of Parkinson’s disease, dystonia and epilepsy, together with rising demand for painless and wireless rechargeable systems are expected to fuel the market growth

Vancouver, Dec. 12, 2023 (GLOBE NEWSWIRE) — The global Deep Brain Stimulation (DBS) market, valued at USD 1.70 Billion in 2022, is projected to witness a robust revenue Compound Annual Growth Rate (CAGR) of 9.6% during the forecast period. A surge in Parkinson’s Disease (PD) diagnoses, particularly among the elderly, and increased life expectancy contribute to this growth. The prevalence of PD has witnessed a 50% rise in the U.S. alone, reaching over 90,000 cases in 2022. As a primary treatment for conditions like Parkinson’s disease and epilepsy, there is a soaring demand for Deep Brain Stimulation.

DBS proves crucial for Parkinson’s patients facing diminishing medication effectiveness and escalating side effects due to increased dosages. In contrast, DBS restores efficacy with lower medication doses, providing symptom management while minimizing adverse effects, thereby fueling market growth.


The market is further propelled by the development of innovative DBS systems. The introduction of Directional DBS, a significant advancement, allows for precise adjustment of electric current both vertically and horizontally, targeting specific areas of the brain linked to patient symptoms. The U.S. Food and Drug Administration (FDA) approval of Boston Scientific’s Vercise device, utilizing directional DBS for treating Parkinson’s tremors, exemplifies the growing acceptance of these advanced systems.

However, challenges such as high expenses, limited availability in developing countries, and issues in administering appropriate dosages pose obstacles to widespread DBS adoption. Additionally, hardware complications like lead movement, battery failures, and the risk of device-related infections hinder the market’s growth.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

Application Mode Insights

In the application segment, Parkinson’s disease is anticipated to dominate the market during the forecast period. DBS proves particularly effective in alleviating motor symptoms associated with Parkinson’s, such as tremors, stiffness, and slowness of movement. The Obsessive Compulsive Disorder (OCD) segment is also expected to witness significant growth, driven by the rising prevalence of OCD and the success rate of DBS in treating patients unresponsive to conventional therapies.

End-use Insights

Hospitals lead the end-use segment, capturing the largest revenue share, attributed to advanced facilities and improved healthcare infrastructure in developing countries. Specialized neurological hospitals further contribute to the segment’s growth. The ambulatory surgical centers segment is poised for steady revenue growth due to safety, comfort, and cost-effectiveness, making them an attractive option for older adults.

Regional Insights

North America commands the largest revenue share, fueled by increasing regulatory approvals and the presence of key market players. The FDA’s recent Breakthrough Device Designation for Abbott’s DBS system for treating Treatment-Resistant Depression underscores the region’s commitment to advancing DBS technology. In Asia Pacific, the market is expected to witness the fastest revenue CAGR, driven by innovative technological trends and rapid adoption of Artificial Intelligence (AI) and Machine Learning (ML). Europe follows closely, registering a steadily fast revenue growth rate, with key players introducing innovative products to cater to the growing demand for advanced DBS solutions.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

Scope of Research

Report Details Outcome
Market size in 2022 USD 1.70 Billion
CAGR (2023–2032) 9.6%
Revenue forecast to 2032 USD 4.27 Billion
Base year for estimation 2022
Historical data 2019–2021
Forecast period 2023–2032
Quantitative units Revenue in USD Million and CAGR in % from 2023 to 2032
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Product type, application, end-use, and region
Regional scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Country scope U.S., Canada, Mexico, Germany, U.K., France, Spain, BENELUX, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, U.A.E., Israel, and Rest of MEA
Key companies profiled Abbott Laboratories, Medtronic plc, ALEVA NEUROTHERAPEUTICS, NeuroPace, Inc., Boston Scientific Corporation, CYBERONICS, Fisher Wallace, SceneRay Co., Ltd, Functional Neuromodulation, Ltd, and Renishaw plc
Customization scope 10 hours of free customization and expert consultation

Major Companies and Competitive Landscape

The global deep brain stimulation market is fragmented, with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective deep brain stimulation.

Some major players included in the global deep brain stimulation market report are:

  • Abbott Laboratories
  • Medtronic plc
  • NeuroPace, Inc.
  • Boston Scientific Corporation
  • Fisher Wallace
  • SceneRay Co., Ltd
  • Functional Neuromodulation, Ltd
  • Renishaw plc.

Strategic Development

  • On 18 August 2022, in order to create a comprehensive and innovative Deep Brain Stimulation (DBS) program for Parkinson’s patients in India, Aster Medcity and India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic plc, have joined forces.
  • Together with Medtronic’s full line of DBS technology, technical experience, and support, Aster’s teams with their medical and surgical competence in DBS therapy assist the Aster Centre for Parkinson’s and Movement Disorder through this relationship. We are pleased to announce that Aster Medcity Kochi has become the first facility in South Asia to use the newest generation of the Microelectrode recording system for DBS procedures from Medtronic, the NeuroNav MER system (Alpha Omega).

Direct Order Can Be Placed Through This Link [Exclusive Copy] @

For the purpose of this report, Emergen Research has segmented the global deep brain stimulation market on the basis of product type, application, end-use, and region:

  • Product Type Outlook (Revenue, USD Billion; 2019–2032)
    • Dual Channel
    • Single Channel
    • Rechargeable DBS Systems
    • Non-Rechargeable DBS Systems
  • Application Outlook (Revenue, USD Billion; 2019–2032)
    • Fluid Replacement
    • Parkinson’s Disease
        • Motor Symptoms
            • Tremors
            • Bradykinesia (slowness of movement)
            • Rigidity
        • Non-Motor Symptoms
            • Cognitive Impairment
            • Mood Disorders
            • Sleep Disorders
    • Pain Management
    • Obsessive Compulsive Disorder (OCD)
        • Obsessions
        • Compulsions
    • Epilepsy
        • Focal Seizures
        • Generalized Seizures
    • Essential Tremor
        • Hand Tremor
        • Voice Tremor
        • Head Tremor
    • Depression
        • Treatment-Resistant Depression
    • Dystonia
        • Generalized Dystonia
        • Focal Dystonia
    • Others
  • End-use Outlook (Revenue, USD Billion; 2019–2032)
    • Hospitals
    • Ambulatory Surgical Centers
        • Standalone Ambulatory Surgical Centers
        • Hospital-affiliated Ambulatory Surgical Centers
    • Neurology Clinics
  • Regional Outlook (Revenue, USD Million, 2019–2032)
    • North America
        • U.S.
        • Canada
        • Mexico
    • Europe
        • Germany
        • U.K.
        • France
        • Spain
        • BENELUX
        • Rest of Europe
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of APAC
    • Latin America
        • Brazil
        • Rest of LATAM
    • Middle East & Africa
        • Saudi Arabia
        • U.A.E.
        • Israel
        • Rest of MEA

Browse Full Report Description + Research Methodology + Table of Content + Infographics@  

Curated Reports You Shouldn’t Miss: Dive In Now!

Operating Room Integration Systems Market By Device Type (Audio Video Management System, Display System, Documentation Management System), By End-Use, By Application (General Surgery, Orthopedic Surgery, Neurosurgery), Forecasts to 2027

Precision Medicine Market By Technology (Big-Data Analytics and Bioinformatics), By Application (Oncology and CNS), By End-Use (Pharmaceutical Companies and Healthcare IT Companies), and By Region Forecast to 2030

Microfluidics Market, By Material Type (Polymer, Silicon, Glass, Others), By Application (Point-of-Care Testing, Drug Delivery Systems, Others), By Components (Microfluidic Chips, Micropumps, Microneedles, Others), and By Region Forecast to 2030

Femtech Market By Type (Devices, Software, Services), By End-Use (Direct-to-Consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers), By Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare), By Region, Forecasts to 2027

Sports Medicine Market By Product (Body Reconstruction Products, Body Support and Recovery Products), By Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries), By Body Monitoring and Evaluation Devices, By End-Use, and By Region, and By Region, Forecasts to 2027

Advanced Wound Care Market By Product Type (Moist Wound Dressing, Wound Therapy Devices), By Wound Type (Surgical Wounds, Ulcers, Burns, Traumatic Wounds), By End-User (Hospitals and Clinics, Home Care Settings), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Explore Our Blogs and Insights Section:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.